The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Tags · Evidence

FLOW trial

Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease.

0 topics 0 solved Group: Evidence

Related in this group: STEP programme · SURMOUNT programme · SURPASS programme · SELECT trial · SOUL trial · TRIUMPH programme · PIONEER programme · SUSTAIN programme · LEADER trial · randomised trial · meta-analysis · observational data

0 topics

No topics here yet

This listing is empty. That is unusual and probably means the filter is narrower than the content.